Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......
Political leaders cutting across party lines have joined hands with the civil society to launch a nationwide campaign against GM crops and the Biotechnology Regulatory Authority of India Bill. The......
The government on Monday said there will be no compromise on nuclear safety or livelihood of any section of society in India's pursuit of atomic power, a statement that comes against the backdrop......
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots......
Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......
While the moratorium on the commercial introduction of Bt brinjal will continue for now, it may not last indefinitely. Prime Minister Manmohan Singh, who addressed the issue among his combative......
With India updating its patents law, the rules of the game have changed for Indian biotechnology companies. They are repositioning themselves for increased competition and emphasis on new niches.......
Following are the highlights of the economic agenda unveiled by President A P J Abdul Kalam at the joint sitting of Parliament on Thursday:GDP growth likely to cross 8% in 2005-06.Inflation modest......
Common curriculum for biotechnology at all universities across the country, inclusion of livestock in the draft strategy for biotechnology and removal of regulatory hurdles are some of the......
Lauding the government's initiative of unveiling a National Biotechnology Policy, industry experts said that it was imperative that this policy was implemented in a timebound manner and that the......